Literature DB >> 11360311

Proliferative capacity in head and neck cancer.

H Struikmans1, H B Kal, G J Hordijk, I van der Tweel.   

Abstract

BACKGROUND: Shortening of overall treatment time (accelerated radiotherapy) appears to result in an increase of the efficacy of irradiation. In this study, we compared the proliferative capacity between tumors originating in different sites of the head and neck region. Tumors with a large proliferating capacity might, theoretically, benefit most from accelerated radiotherapy.
MATERIAL AND METHODS: BrdUrd was administered intravenously in patients with head and neck carcinomas. Tumor samples were analyzed with flow cytometry. T and N stages were assessed in accordance with the TNM classification system (UICC 1987).
RESULTS: No significant differences in proliferation parameters were observed with respect to site of origin of head and neck tumors. For T3/T4 tumors, DNA ploidy is an important tumor characteristic: G1- and S-phase fractions, labeling index, and tumor doubling time Tpot differences were statistically significant; the aneuploid tumors showed the largest proliferative potential.
CONCLUSIONS: (1) In general, no significant differences in proliferation parameters were observed with respect to site of origin. (2) Aneuploid head and neck tumors have a higher proliferative capacity than diploid ones, they might benefit most from accelerated irradiation. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360311     DOI: 10.1002/hed.1064

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

Review 1.  Determinants and clinical implications of chromosomal instability in cancer.

Authors:  Laurent Sansregret; Bart Vanhaesebroeck; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2018-01-03       Impact factor: 66.675

2.  Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials.

Authors:  Yingyu Liu; Changgui Kou; Yingying Su; Yangyu Zhang; Yueyue You; Lili Zhang; Mohan Wang; Yingli Fu; Xiaojun Ren; Yanming Yang
Journal:  Onco Targets Ther       Date:  2017-06-13       Impact factor: 4.147

3.  Accelerated Hyperfractionated Radiotherapy versus Conventional Fractionation Radiotherapy for Head and Neck Cancer: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Bo Zhu; Changgui Kou; Wei Bai; Weiying Yu; Lili Zhang; Xiao Yu; Wen Xu; Huanhuan Wang; Ying Xin; Xin Jiang
Journal:  J Oncol       Date:  2019-11-28       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.